The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Therapeutics, Inc. | COM | 00461U105 | 4,225 | 2,608,117 | SH | SOLE | 2,608,117 | 0 | 0 | ||
| Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 8,949 | 967,500 | SH | SOLE | 967,500 | 0 | 0 | ||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | 3,886 | 232,571 | SH | SOLE | 232,571 | 0 | 0 | ||
| Akero Therapeutics, Inc. | COM | 00973Y108 | 554 | 22,234 | SH | SOLE | 22,234 | 0 | 0 | ||
| Allakos Inc | COM | 01671P100 | 17,524 | 243,868 | SH | SOLE | 243,868 | 0 | 0 | ||
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | 346 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| Aravive Inc | COM | 03890D108 | 6,705 | 576,066 | SH | SOLE | 576,066 | 0 | 0 | ||
| Assembly Biosciences Inc. | COM | 045396108 | 694 | 29,740 | SH | SOLE | 29,740 | 0 | 0 | ||
| Atreca Inc | COM | 04965G109 | 10,859 | 510,296 | SH | SOLE | 510,296 | 0 | 0 | ||
| Bellus Health Inc | COM | 07987C204 | 3,450 | 333,631 | SH | SOLE | 333,631 | 0 | 0 | ||
| Catabasis Pharmaceuticals Inc | COM | 14875P206 | 1,929 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Forma Therapeutics Holdings, Inc. | COM | 34633R104 | 73,379 | 1,578,388 | SH | SOLE | 1,578,388 | 0 | 0 | ||
| Fulcrum Therapeutics, Inc. | COM | 359616109 | 5,379 | 294,118 | SH | SOLE | 294,118 | 0 | 0 | ||
| Genron Corporation | COM | 374163103 | 8,481 | 3,890,220 | SH | SOLE | 3,890,220 | 0 | 0 | ||
| Hookipa Pharma Inc | COM | 43906K100 | 4,651 | 400,245 | SH | SOLE | 400,245 | 0 | 0 | ||
| Intercept Pharmaceuticals Inc | COM | 45845P108 | 19,341 | 403,688 | SH | SOLE | 403,688 | 0 | 0 | ||
| Iveric Bio, Inc. | COM | 46583P102 | 17,189 | 3,370,478 | SH | SOLE | 3,370,478 | 0 | 0 | ||
| Kala Pharmaceuticals Inc | COM | 483119103 | 3,564 | 339,102 | SH | SOLE | 339,102 | 0 | 0 | ||
| KalVista Pharmaceuticals Inc | COM | 483497103 | 2,035 | 168,174 | SH | SOLE | 168,174 | 0 | 0 | ||
| NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 959 | 48,602 | SH | SOLE | 48,602 | 0 | 0 | ||
| Odonate Therapeutics Inc | COM | 676079106 | 21,022 | 496,505 | SH | SOLE | 496,505 | 0 | 0 | ||
| Pieris Pharmaceuticals Inc | COM | 720795103 | 5,203 | 1,620,249 | SH | SOLE | 1,620,249 | 0 | 0 | ||
| Portola Pharmaceuticals Inc | COM | 737010108 | 5,279 | 318,429 | SH | SOLE | 318,429 | 0 | 0 | ||
| Principia Biopharma Inc | COM | 74257L108 | 20,505 | 342,946 | SH | SOLE | 342,946 | 0 | 0 | ||
| Rhythm Pharmaceuticals Inc | COM | 76243J105 | 6,161 | 276,289 | SH | SOLE | 276,289 | 0 | 0 | ||
| Rocket Pharmaceuticals Inc | COM | 77313F106 | 2,892 | 138,197 | SH | SOLE | 138,197 | 0 | 0 | ||
| Soleno Therapeutics, Inc. | COM | 834203200 | 1,665 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| Springworks Therapeutics Inc | COM | 85205L107 | 23,409 | 557,356 | SH | SOLE | 557,356 | 0 | 0 | ||
| Sutro BioPharma Inc | COM | 869367102 | 13,002 | 1,675,579 | SH | SOLE | 1,675,579 | 0 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q107 | 15,866 | 1,571,903 | SH | SOLE | 1,571,903 | 0 | 0 | ||
| Urovant Sciences Ltd | COM | G9381B108 | 1,550 | 157,480 | SH | SOLE | 157,480 | 0 | 0 | ||
| Verona Pharma PLC. | SPONSORED ADS | 925050106 | 203 | 43,456 | SH | SOLE | 43,456 | 0 | 0 | ||